EndoGastric Solutions Stock

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Sign up today and learn more about EndoGastric Solutions Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About EndoGastric Solutions Stock

EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.

Funding History

June 2003$5.0M
September 2004$12.0M
February 2006$32.0M
August 2007$30.0M
June 2009$3.8M
July 2009$7.5M
October 2009$9.5M
November 2009$21.5M
August 2010$30.0M
March 2012$10.9M
April 2012$2.1M
June 2012$13.0M
February 2013$10.0M
April 2014$1.0M
May 2014$30.0M
April 2015$1.3M
May 2015$10.0M
December 2015$50.0M
June 2018$40.6M
May 2019$15.0M
December 2020$27.0M


President & CEO

Skip Baldino

Corporate Compliance Officer

Steve Hoffman

Vice President, Marketing and Professional Education

Ted Stephens

Vice President, R&D, Operations

Darren Crow

Chief Financial Officer

Michael Burke

Vice President of Human Asset Development.

Patrick Crilly

PhD Vice President, Healthcare Economics, Policy and Reimbursement

Philip Macdonald

VP of Marketing

Josh DeFonzo

Board Member

Kathleen Regan


Kunal Paymaster

Board Member

Brent Ahrens

Board of Directors

Jordan S. Davis

Board Member

Mike Carusi


Mike Carusi

Board of Directors

Uri Geiger

Member of the Board of Directors

Floyd Loop

Board of Directors

Arda Minocherhomjee

Chief Medical Officer - Medical Doctor - Surgeon

Adrian Lobontiu

Medical Director

Adrian Lobontiu

Board Member

Alejandro Sanchez

Medical Advisory Board

Reginald Bell

Medical Advisory Board

John Hunter

Board Member

Guy Jordan

Medical Advisory Board

Blair Jobe

Vice President, Sales

Martin Reid

Member of the Board of Directors

Joe Mandato

Board of Directors

Lee Wrubel


xconomy - Sep, 29 2015

$30M Series F for EndoGastric

xconomy - May, 22 2015

EndoGastric Gets $7.5M | Xconomy

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: